The diagnostic accuracy of increased late night salivary cortisol for Cushing’s syndrome: a real-life prospective study
- 69 Downloads
Introduction and aim
A prompt diagnosis of Cushing’s Syndrome (CS) in high-risk populations is mandatory: 1-mg dexamethasone suppression test (1-mg DST), late night salivary cortisol (LNSC), and urinary-free cortisol (UFC) are recommended, despite thresholds calculated in retrospective studies. Our aim was to study the diagnostic accuracy of LNSC measured with chemiluminescence assay in a prospective study, confirming discrepancies with mass spectrometry (MS).
Materials and methods
We enrolled 117 controls and 164 suspected CS (CS = 47, non-CS = 117). In case of increased LNSC, high clinical suspicion of CS or adrenal incidentaloma, patients were hospitalized to exclude/confirm CS.
LNSC levels were higher in patients with suspected CS, CS, and non-CS than controls. Considering 16 nmol/L as threshold for CS, overall LNSC revealed SE 97% and SP 84% in the whole group of subjects considered, achieving positive/negative likelihood ratio of 5.56/0.045, respectively. 35 out of 81 subjects with increased LNSC were non-CS (15 diabetic and 20 obese): considering only those patients with increased likelihood to have a CS (the non-CS patients) SP decreased to 70%, and further reduced to 60% if we discharged subjects with adrenal incidentaloma. MS analyses reduced partially the number of false-positive LNSC.
LNSC measured in automated chemiluminescence is reliable in clinical practice: it present a high diagnostic accuracy to exclude hypercortisolism in patients with normal cortisol levels. MS could be used to reduce the number of false-positive results; nevertheless, some non-CS subjects with functional hypercortisolism could have a mild impairment of cortisol rhythm.
KeywordsCushing’s syndrome Late night salivary cortisol Diagnosis Liquid chromatography–tandem mass spectrometry
Authors are grateful to prof. Carla Scaroni for the critical review of the manuscript.
This study did not receive any specific grant from any funding agency in the public, commercial, or not-for-profit sector.
Compliance with ethical standards
Conflict of interest
All authors declare that they have no conflicts of interest that might be perceived as influencing the impartiality of the reported research.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- 7.Ceccato F, Barbot M, Zilio M, Ferasin S, Occhi G, Daniele A, Mazzocut S, Iacobone M, Betterle C, Mantero F, Scaroni C (2013) Performance of salivary cortisol in the diagnosis of cushing’s syndrome, adrenal incidentaloma, and adrenal insufficiency. Eur J Endocrinol 169:31–36CrossRefPubMedGoogle Scholar
- 9.Belaya ZE, Iljin AV, Melnichenko GA, Rozhinskaya LY, Dragunova NV, Dzeranova LK, Butrova SA, Troshina EA, Dedov II (2012) Diagnostic performance of late-night salivary cortisol measured by automated electrochemiluminescence immunoassay in obese and overweight patients referred to exclude cushing’s syndrome. Endocrine 41:450–494CrossRefGoogle Scholar
- 10.Carrasco CA, García M, Goycoolea M, Cerda J, Bertherat J, Padilla O, Meza D, Wohllk N, Quiroga T (2012) Reproducibility and performance of one or two samples of salivary cortisol in the diagnosis of Cushing’s Syndrome using an automated immunoassay system. Endocrine 41:487–493CrossRefPubMedGoogle Scholar
- 14.Trementino L, Zilio M, Marcelli G, Michetti G, Barbot M, Ceccato F, Boscaro M, Scaroni C, Arnaldi G (2015) The role of an acute pasireotide suppression test in predicting response to treatment in patients with Cushing’s Disease: findings from a pilot study. Endocrine 50:154–161CrossRefPubMedGoogle Scholar
- 19.Manetti L, Rossi G, Grasso L, Raffaelli V, Scattina I, Del Sarto S, Cosottini M, Iannelli A, Gasperi M, Bogazzi F, Martino E (2013) Usefulness of salivary cortisol in the diagnosis of hypercortisolism: comparison with serum and urinary cortisol. Eur J Endocrinol 168:315–321CrossRefPubMedGoogle Scholar
- 22.Carrozza C, Corsello SM, Paragliola RM, Ingraudo F, Palumbo S, Locantore P, Sferrazza A, Pontecorvi A, Zuppi C (2010) Clinical accuracy of midnight salivary cortisol measured by automated electrochemiluminescence immunoassay method in Cushing’s Syndrome. Ann Clin Biochem 47:228–232CrossRefPubMedGoogle Scholar
- 23.Repetto EM, Gonzalez D, Jacobsen D, Smithuis F, Jamardo J, Cano M, Aranda C, Oneto A, Berg G, Fabre B (2017) Evaluation of an automated chemiluminescent immunoassay for salivary cortisol measurement. Utility in the diagnosis of Cushing’s syndrome. Clin Chem Lab Med 1:e65–e68. https://doi.org/10.1515/cclm-2016-0585 CrossRefGoogle Scholar
- 26.Masserini B, Morelli V, Bergamaschi S, Ermetici F, Eller-Vainicher C, Barbieri AM, Maffini MA, Scillitani A, Ambrosi B, Beck-Peccoz P, Chiodini I (2009) The limited role of midnight salivary cortisol levels in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentaloma. Eur J Endocrinol 160:87–92CrossRefPubMedGoogle Scholar
- 27.Palmieri S, Morelli V, Polledri E, Fustinoni S, Mercadante R, Olgiati L, Eller Vainicher C, Cairoli E, Zhukouskaya VV, Beck-Peccoz P, Chiodini I (2013) The role of salivary cortisol measured by liquid chromatography-tandem mass spectrometry in the diagnosis of subclinical hypercortisolism. Eur J Endocrinol 168:289–296CrossRefPubMedGoogle Scholar
- 36.Di Dalmazi G, Vicennati V, Garelli S, Casadio E, Rinaldi E, Giampalma E, Mosconi C, Golfieri R, Paccapelo A, Pagotto U, Pasquali R (2014) Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical cushing’s syndrome: a 15-year retrospective study. Lancet Diabetes Endocrinol 2:396–405CrossRefPubMedGoogle Scholar